GMPs stayed center stage for FDA and the industry: FDA’s Dr Daniel Fabricant told NutraIngredients-USA at the recent SupplySide show : “There is not a clear indication there will be a drop in non-compliance anytime soon, and that concerns us.”
Dr Fabricant, Director of FDA’s Division of Dietary Supplement Programs, said that the industry will see a lot more strong GMP enforcement action like injunctions and seizures.
There were also predictions from leading industry figures that once FDA inspectors get past the initial tier of GMP compliance issues, that we could see a wave of warning letters linked to finished product testing:
Memory, attention and focus, development, mood; there are numerous ways that a nutrient or ingredient can affect...
High levels changes happened this month at NOW Foods, LycoRed, Gaia Herbs, and Robinson Pharma all announcing...